CSIMarket
 
Healthcare Sector

The Largest Companies in Major Pharmaceutical Preparations Industry  




 

The Largest Companies by Market Capitalization, Revenues, Income and Employees within Major Pharmaceutical Preparations Industry


  Marketcap Revenues (TTM) Net Income (TTM) Employees
Company (Millions) (Millions) (Millions) Number
Eli Lilly And Company $ 686,915 $ 49,003 $ 11,106 43,000
Johnson and Johnson $ 363,061 $ 89,331 $ 21,810 134,400
Beigene Ltd $ 357,093 - $ 0 -
Abbvie Inc $ 328,352 $ 57,367 $ 4,203 50,000
Novartis Ag $ 242,191 $ 46,660 $ 14,854 109,000
Abbott Laboratories $ 232,363 $ 42,344 $ 13,502 114,000
Merck and Co Inc $ 199,774 $ 63,922 $ 17,451 72,000
Pfizer Inc $ 136,869 $ 62,463 $ 7,912 88,000
Vertex Pharmaceuticals Inc $ 114,406 $ 11,100 $ -989 5,400
Astrazeneca Plc $ 109,262 $ 45,811 $ 5,961 83,100
Bristol myers Squibb Company $ 95,907 $ 47,636 $ 5,437 34,100
Zoetis Inc $ 70,412 $ 9,286 $ 2,528 14,100
Verona Pharma Plc $ 64,081 - $ -164 79
Akari Therapeutics Plc $ 61,139 - $ -18 12
Sanofi $ 60,117 $ 49,600 $ 6,292 100,000
Regeneron Pharmaceuticals Inc $ 56,681 $ 14,086 $ 4,499 13,450
Alnylam Pharmaceuticals Inc $ 40,161 $ 2,348 $ -270 2,100
Zai Lab Limited $ 37,343 $ 418 $ -252 656
Horizon Therapeutics Public Limited Company $ 27,190 $ 3,643 $ 438 1,300
Takeda Pharmaceutical Company Limited $ 23,342 $ 29,167 $ 986 50,000
Royalty Pharma Plc $ 20,153 $ 2,264 $ 1,769 89
Teva Pharmaceutical Industries Limited $ 19,645 $ 16,617 $ -1,320 37,851
Insmed Inc $ 18,571 $ 272 $ -1,013 400
Summit Therapeutics Inc $ 15,175 $ 2 $ -241 105
United Therapeutics Corporation $ 14,130 $ 2,994 $ 1,211 1,168
Intra cellular Therapies Inc $ 13,677 $ 681 $ -75 202
Hutchmed china Limited $ 12,953 $ 630 $ 38 467
Karuna Therapeutics Inc $ 12,431 $ 11 $ -396 10
Legend Biotech Corporation $ 11,987 $ 285 $ -518 800
Catalent Inc $ 11,534 $ 4,422 $ -413 16,900
Biomarin Pharmaceutical Inc $ 10,806 $ 2,950 $ 524 3,401
Viatris Inc $ 10,577 $ 14,330 $ -3,790 38,000
Theralink Technologies Inc $ 9,596 $ 1 $ -60 -
Prometheus Biosciences Inc $ 9,488 $ 4 $ -151 143
Immunogen inc $ 8,981 $ 288 $ -74 346
Corcept Therapeutics Inc $ 8,553 $ 685 $ 133 352
Blueprint Medicines Corporation $ 8,529 $ 562 $ -156 582
Roivant Sciences Ltd $ 8,205 $ 98 $ -357 750
Cerevel Therapeutics Holdings Inc $ 8,165 - $ -460 260
Bridgebio Pharma Inc $ 7,935 $ 127 $ -677 260
Pharming Group N v $ 7,521 $ 245 $ -11 304
Reata Pharmaceuticals Inc $ 7,154 $ 3 $ -88 350
Elanco Animal Health Incorporated $ 6,718 $ 4,427 $ 373 9,300
Jazz Pharmaceuticals Plc $ 6,556 $ 4,065 $ 482 2,800
Madrigal Pharmaceuticals Inc $ 6,312 $ 317 $ -392 53
Ionis Pharmaceuticals Inc $ 5,938 $ 941 $ -319 927
Tg Therapeutics Inc $ 5,863 $ 386 $ 39 132
Iveric Bio Inc $ 5,477 - $ -223 105
Nuvalent Inc $ 5,371 $ 4 $ -301 142
Biophytis Sa $ 5,270 - $ -19 20
Amarin Corp Plcuk $ 5,184 $ 214 $ -88 1,650
Axsome Therapeutics Inc $ 4,921 $ 449 $ -284 48
Alkermes Plc $ 4,909 $ 1,514 $ 353 2,100
Puretech Health Plc $ 4,774 $ 3 $ -67 118
Redhill Biopharma Ltd $ 4,544 $ 7 $ 24 24
Ptc Therapeutics inc $ 4,337 $ 900 $ 679 995
Akero Therapeutics Inc $ 4,263 - $ -269 56
Prestige Consumer Healthcare Inc $ 4,174 $ 1,137 $ 499 570
Alpine Immune Sciences Inc $ 4,160 $ 57 $ -37 25
Biolinerx Ltd $ 4,085 $ 5 $ -61 133
Rhythm Pharmaceuticals inc $ 3,909 $ 137 $ -174 111
Cytokinetics Incorporated $ 3,843 $ 19 $ -615 141
Mirati Therapeutics Inc $ 3,815 $ 38 $ -726 450
Acadia Pharmaceuticals Inc $ 3,808 $ 996 $ 229 598
Avidity Biosciences Inc $ 3,788 $ 10 $ -386 202
Structure Therapeutics Inc $ 3,739 - $ -143 93
Merus N v $ 3,665 $ 55 $ -277 105
Perrigo Company Plc $ 3,649 $ 4,334 $ -180 11,000
Ultragenyx Pharmaceutical Inc $ 3,576 $ 591 $ -550 1,276
Cymabay Therapeutics Inc $ 3,457 - $ -105 68
Protagonist Therapeutics inc $ 3,358 $ 208 $ 56 112
Citius Oncology Inc $ 3,148 - $ -6 -
Viking Therapeutics Inc $ 2,915 - $ -128 14
Chinook Therapeutics Inc $ 2,892 $ 6 $ -246 79
Morphic Holding inc $ 2,855 $ 75 $ -180 31
Catalyst Pharmaceuticals Inc $ 2,854 $ 535 $ 197 106
Crinetics Pharmaceuticals Inc $ 2,808 $ 5 $ -328 68
Moonlake Immunotherapeutics $ 2,751 - $ -148 31
Lyell Immunopharma Inc $ 2,564 $ 0 $ -335 154
Organon and Co $ 2,545 $ 6,294 $ 750 10,000
Dr Reddy s Laboratories Limited $ 2,534 $ 3,350 $ 668 22,000
Amneal Pharmaceuticals Inc $ 2,533 $ 2,869 $ -74 7,700
Xenon Pharmaceuticals Inc $ 2,522 $ 13 $ -251 142
Mirum Pharmaceuticals Inc $ 2,461 $ 379 $ -77 90
Cybin Inc $ 2,453 $ 71 $ -60 30
Kazia Therapeutics Limited $ 2,412 $ 2 $ -27 17
Longboard Pharmaceuticals Inc $ 2,336 - $ -76 37
Can Fite Biopharma Ltd $ 2,296 $ 1 $ -8 -
Bausch Health Companies Inc $ 2,284 $ 9,731 $ -81 20,270
Dice Therapeutics Inc $ 2,250 - $ -104 57
Deciphera Pharmaceuticals Inc $ 2,236 $ 175 $ -190 355
Mereo Biopharma Group Plc $ 2,235 $ 36 $ -47 36
Apellis Pharmaceuticals Inc $ 2,219 $ 776 $ -224 705
Metsera Inc $ 2,202 - $ 0 -
Ligand Pharmaceuticals Incorporated $ 2,189 $ 181 $ -133 202
Kiniksa Pharmaceuticals International Plc $ 2,166 $ 481 $ -17 297
Calliditas Therapeutics Ab $ 2,147 $ 129 $ -50 85
Newamsterdam Pharma Company N v $ 2,088 $ 47 $ 0 150
Arrowhead Pharmaceuticals Inc $ 2,060 $ 278 $ -155 211
Agios Pharmaceuticals Inc $ 1,992 $ 37 $ 674 383
Sarepta Therapeutics Inc $ 1,955 $ 2,233 $ -248 1,314
Immutep Limited $ 1,920 $ 8 $ -43 40
Ideaya Biosciences Inc $ 1,915 $ 50 $ -307 104
Harmony Biosciences Holdings inc $ 1,866 $ 744 $ 153 246
Belite Bio Inc $ 1,847 - $ -36 60
Galapagos Nv $ 1,807 $ 268 $ 237 588
Supernus Pharmaceuticals inc $ 1,803 $ 668 $ 62 652
Nektar Therapeutics $ 1,795 $ 87 $ -133 711
Indivior Plc $ 1,751 $ 1,093 $ 2 1,152
Arcutis Biotherapeutics Inc $ 1,742 $ 213 $ -1 92
Amicus Therapeutics inc $ 1,735 $ 542 $ -29 1,246
Disc Medicine Inc $ 1,720 - $ -116 60
Centessa Pharmaceuticals Plc $ 1,654 - $ -224 401
Taro Pharmaceutical Industries Ltd $ 1,615 $ 573 $ 25 4,300
Rapt Therapeutics Inc $ 1,600 $ 3 $ -117 42
Ars Pharmaceuticals Inc $ 1,580 - $ 8 31
Schrodinger Inc $ 1,495 $ 231 $ -192 378
89bio Inc $ 1,475 - $ -387 19
Biohaven Ltd $ 1,474 $ 860 $ -889 239
Janux Therapeutics Inc $ 1,458 $ 13 $ -78 37
Ocular Therapeutix Inc $ 1,377 $ 60 $ -193 103
Edgewise Therapeutics inc $ 1,360 - $ -146 21
Vera Therapeutics Inc $ 1,328 - $ -175 34
Point Biopharma Global Inc $ 1,322 $ 244 $ 97 100
Innoviva Inc $ 1,317 $ 408 $ -60 648
Ani Pharmaceuticals Inc $ 1,314 $ 674 $ -21 642
Travere Therapeutics Inc $ 1,264 $ 274 $ -227 380
Dynavax Technologies Corporation $ 1,247 $ 295 $ -60 275
Amphastar Pharmaceuticals Inc $ 1,225 $ 722 $ 136 1,761
Aspire Biopharma Holdings Inc $ 1,212 - $ 0 -
Mannkind Corporation $ 1,210 $ 298 $ 30 202
Curevac N v $ 1,201 $ 60 $ -291 370
Cti Biopharma Corp $ 1,196 $ 76 $ -69 80
Dyne Therapeutics Inc $ 1,134 - $ -367 61
Eqrx Inc $ 1,133 - $ -260 250
Pacira Biosciences inc $ 1,127 $ 703 $ -104 1,243
Liquidia Corporation $ 1,122 $ 14 $ -128 82
Aurinia Pharmaceuticals Inc $ 1,113 $ 247 $ 40 48
Harrow Inc $ 1,094 $ 199 $ -17 382
Wave Life Sciences Ltd $ 1,068 $ 105 $ -112 288
Enliven Therapeutics Inc $ 1,066 - $ -95 20
Abcellera Biologics Inc $ 1,015 $ 23 $ -168 220
Geron Corp $ 1,006 $ 116 $ -139 18
Collegium Pharmaceutical inc $ 980 $ 498 $ 44 337
Phibro Animal Health Corporation $ 972 $ 1,190 $ 32 1,940
Rayzebio Inc $ 962 - $ 0 52
Nurix Therapeutics Inc $ 960 $ 56 $ -208 117
Zymeworks Inc $ 939 $ 93 $ -114 955
Verve Therapeutics Inc $ 935 $ 32 $ -199 21
Praxis Precision Medicines Inc $ 892 $ 9 $ -213 82
Akebia Therapeutics Inc $ 889 $ 185 $ -45 410
Avadel Pharmaceuticals Plc $ 887 $ 194 $ -26 154
Opko Health Inc $ 866 $ 689 $ -39 3,930
Arrivent Biopharma inc $ 855 - $ -127 52
Ardelyx inc $ 850 $ 362 $ -54 52
Arcus Biosciences Inc $ 848 $ 141 $ -391 21,164
Silence Therapeutics Plc $ 843 $ 25 $ -43 116
Gyre Therapeutics Inc $ 823 $ 101 $ 12 18
Cogent Biosciences Inc $ 819 $ 8 $ -269 102
Syndax Pharmaceuticals Inc $ 817 $ 44 $ -331 56
Cormedix Inc $ 813 $ 0 $ -18 25
Avid Bioservices Inc $ 797 $ 151 $ -152 371
Intercept Pharmaceuticals inc $ 794 $ 288 $ -62 375
Elite Pharmaceuticals Inc $ 793 $ 70 $ -18 64
Unicycive Therapeutics Inc $ 785 - $ -15 11
Chimerix Inc $ 763 $ 33 $ -88 201
Uniqure N v $ 755 $ 20 $ -218 80
Phathom Pharmaceuticals Inc $ 750 $ 82 $ -346 55
Mineralys Therapeutics Inc $ 717 - $ -189 23
Anaptysbio inc $ 710 $ 112 $ -141 49
Trevi Therapeutics Inc $ 701 - $ -47 26
Urogen Pharma Ltd $ 695 $ 91 $ -138 201
Stoke Therapeutics Inc $ 688 $ 191 $ 50 128
Xeris Biopharma Holdings Inc $ 688 $ 223 $ 36 65
Nuvation Bio Inc $ 667 $ 11 $ -606 43
Evotec Se $ 665 $ 875 $ -94 2,200
Oric Pharmaceuticals Inc $ 661 - $ -133 74
Arbutus Biopharma Corp $ 654 $ 6 $ -146 57
Morphosys Ag $ 651 $ 267 $ -213 511
Day One Biopharmaceuticals Inc $ 649 $ 162 $ -79 49
Sinovac Biotech Ltd $ 644 $ 448 $ -258 1,000
Gh Research Plc $ 644 - $ -36 -
Kalvista Pharmaceuticals Inc $ 640 $ 13 $ -176 45
Addex Therapeutics Ltd $ 638 $ 2 $ -11 17
Xencor Inc $ 629 $ 127 $ -211 280
Dianthus Therapeutics Inc $ 603 $ 7 $ -101 19
Evolus Inc $ 591 $ 380 $ -56 130
Upstream Bio Inc $ 583 - $ 0 -
Fibrogen Inc $ 580 $ 180 $ -10 333
Oculis Holding Ag $ 576 $ 1 $ -89 -
Sage Therapeutics Inc $ 575 $ 47 $ -354 353
Tango Therapeutics Inc $ 569 $ 41 $ -132 78
Benitec Biopharma Inc $ 564 $ 0 $ -27 16
Keros Therapeutics Inc $ 553 $ 239 $ 4 92
Thorne Healthtech Inc $ 549 $ 256 $ 20 202
Tyra Biosciences Inc $ 548 - $ -96 60
Arvinas Inc $ 541 $ 427 $ -47 202
Altimmune inc $ 531 $ 0 $ -90 59
Theravance Biopharma inc $ 528 $ 65 $ -58 202
Regulus Therapeutics Inc $ 521 $ 0 $ -48 34
Xtl Biopharmaceuticals Ltd $ 518 - $ -1 14
Bicycle Therapeutics Plc $ 513 $ 26 $ -203 61
Kura Oncology Inc $ 511 - $ -182 89
Bicara Therapeutics Inc $ 508 - $ 0 55
Zevra Therapeutics Inc $ 489 $ 41 $ -92 23
I mab $ 467 $ 4 $ -22 -
Septerna Inc $ 460 - $ 0 -
Compass Pathways Plc $ 457 - $ -138 76
Immunome Inc $ 451 $ 13 $ -158 35
Savara Inc $ 445 - $ -102 25
Siga Technologies Inc $ 437 $ 120 $ 49 46
Fulcrum Therapeutics Inc $ 437 $ 11 $ -1 80
Amylyx Pharmaceuticals Inc $ 433 $ 196 $ -219 113
Chemomab Therapeutics Ltd $ 431 - $ 14 40
Xoma Royalty Corporation $ 428 $ 43 $ -10 13
Precigen Inc $ 426 - $ -157 99
Organogenesis Holdings Inc $ 408 $ 459 $ -20 862
Atai Life Sciences N v $ 398 $ 0 $ -150 202
Kamada Ltd $ 398 $ 143 $ 8 572
Heron Therapeutics Inc $ 394 $ 148 $ -8 328
Erasca Inc $ 388 - $ -158 103
Rapport Therapeutics Inc $ 385 - $ -24 -
Zenas Biopharma Inc $ 384 - $ 0 130
Cytodyn inc $ 381 - $ -7 23
Revance Therapeutics Inc $ 380 $ 247 $ -2 534
Capricor Therapeutics inc $ 377 $ 22 $ -55 11
G1 Therapeutics Inc $ 375 $ 58 $ -45 55
Neurogene Inc $ 373 - $ -81 81
Eton Pharmaceuticals Inc $ 365 $ 48 $ -5 31
Terns Pharmaceuticals Inc $ 357 - $ -90 59
Emergent Biosolutions Inc $ 356 $ 965 $ -132 1,600
Olema Pharmaceuticals Inc $ 353 - $ -129 45
Annexon Inc $ 352 - $ -167 71
Rigel Pharmaceuticals Inc $ 344 $ 203 $ 37 135
Astria Therapeutics Inc $ 340 - $ -108 14
Arcturus Therapeutics Holdings Inc $ 333 $ 144 $ -68 180
Gossamer Bio Inc $ 327 $ 125 $ -51 74
Mbx Biosciences Inc $ 325 - $ 0 -
Cryoport inc $ 318 $ 215 $ -116 31
Aquestive Therapeutics Inc $ 310 $ 54 $ -54 67
Prothena Corporation Public Limited Company $ 308 $ 138 $ -110 173
Alimera Sciences Inc $ 301 $ 98 $ -15 159
Corvus Pharmaceuticals Inc $ 298 - $ -41 31
Rocket Pharmaceuticals Inc $ 297 - $ -258 143
Adc Therapeutics Sa $ 297 $ 76 $ -150 174
Foghorn Therapeutics Inc $ 297 $ 24 $ -80 54
Maravai Lifesciences Holdings Inc $ 295 $ 242 $ -290 1,338
Entrada Therapeutics Inc $ 292 $ 172 $ 49 75
Rezolute Inc $ 288 - $ -73 42
Sagimet Biosciences inc $ 281 - $ -57 111
Atea Pharmaceuticals Inc $ 277 - $ -170 10
Nature s Sunshine Products inc $ 276 $ 455 $ 10 819
Lexicon Pharmaceuticals Inc $ 272 $ 31 $ -177 285
2seventy Bio Inc $ 267 $ 48 $ -4 202
Verastem Inc $ 267 $ 4 $ -149 80
Vanda Pharmaceuticals Inc $ 264 $ 201 $ -44 500
Abivax Sa $ 257 - $ -165 43
Lifecore Biomedical Inc $ 257 $ 131 $ -49 209
Checkpoint Therapeutics inc $ 255 $ 0 $ -57 19
Cartesian Therapeutics Inc $ 253 $ 40 $ -43 66
Inozyme Pharma Inc $ 251 - $ -102 67
Third Harmonic Bio Inc $ 245 - $ 53 53
Palvella Therapeutics Inc $ 243 - $ 0 -
Abeona Therapeutics Inc $ 242 $ 4 $ -64 30
Aslan Pharmaceuticals Limited $ 241 $ 12 $ -44 -
Monopar Therapeutics Inc $ 230 - $ -17 22
Acelyrin Inc $ 229 - $ -269 202
Bolt Biotherapeutics Inc $ 222 $ 4 $ -63 21
Merrimack Pharmaceuticals Inc $ 219 - $ -3 117
Design Therapeutics Inc $ 212 - $ -56 54
Tenax Therapeutics Inc $ 212 - $ 3 10
Esperion Therapeutics Inc $ 210 $ 260 $ -153 72
Spectrum Pharmaceuticals Inc $ 208 $ 109 $ -65 146
Scpharmaceuticals Inc $ 206 $ 42 $ -91 4,375
Hcw Biologics Inc $ 204 $ 1 $ -25 -
Cytomx Therapeutics Inc $ 202 $ 148 $ 42 120
Sol gel Technologies Ltd $ 201 $ 12 $ -11 20
Y mabs Therapeutics inc $ 199 $ 89 $ -28 100
Sensei Biotherapeutics Inc $ 193 - $ -29 14
Tonix Pharmaceuticals Holding Corp $ 192 $ 10 $ -132 70
Omeros Corporation $ 186 - $ -153 50
Aldeyra Therapeutics Inc $ 183 - $ -58 201
Theseus Pharmaceuticals Inc $ 178 - $ -57 34
Aclaris Therapeutics Inc $ 177 $ 18 $ -130 91
Spero Therapeutics Inc $ 167 $ 45 $ -70 75
Lifevantage Corp $ 167 $ 222 $ 9 222
Larimar Therapeutics Inc $ 166 - $ -95 65
Nanobiotix S a $ 164 $ 41 $ -44 81
Tiziana Life Sciences Ltd $ 162 - $ -18 16
Ventyx Biosciences Inc $ 161 - $ -124 79
Puma Biotechnology Inc $ 159 $ 233 $ 38 460
Ac Immune Sa $ 159 $ 15 $ -54 83
Bioage Labs Inc $ 156 $ 2 $ -124 10
Alumis inc $ 155 - $ 0 -
Diamedica Therapeutics Inc $ 155 - $ -27 28
Enanta Pharmaceuticals Inc $ 153 $ 64 $ -96 131
Galectin Therapeutics Inc $ 153 - $ -42 20
Inventiva S a $ 149 $ 46 $ -124 90
Journey Medical Corp $ 147 $ 56 $ -8 19
Alt5 Sigma Corporation $ 147 $ 17 $ -7 -
Aardvark Therapeutics Inc $ 147 - $ 0 -
Eupraxia Pharmaceuticals Inc $ 147 - $ -26 -
Actuate Therapeutics Inc $ 146 - $ -6 16
Landos Biopharma Inc $ 144 - $ 20 27
Nuvectis Pharma inc $ 139 - $ -19 13
Sellas Life Sciences Group Inc $ 135 - $ -27 15
Eledon Pharmaceuticals Inc $ 131 - $ -36 10
Nkarta Inc $ 131 - $ -111 157
Assembly Biosciences Inc $ 131 $ 32 $ -40 73
Pardes Biosciences Inc $ 130 - $ -76 34
Beyondspring Inc $ 128 $ 1 $ -36 -
Paratek Pharmaceuticals Inc $ 127 $ 167 $ -66 71
Ngm Biopharmaceuticals Inc $ 127 $ 4 $ -142 100
Kinnate Biopharma Inc $ 125 - $ -127 99
Contineum Therapeutics Inc $ 123 - $ -50 10
Decibel Therapeutics Inc $ 123 - $ -63 40
Greenwich Lifesciences Inc $ 117 - $ -10 10
Korro Bio Inc $ 116 - $ -87 72
Milestone Pharmaceuticals Inc $ 113 - $ -52 33
Ironwood Pharmaceuticals inc $ 113 $ 318 $ -32 412
Optinose Inc $ 112 $ 91 $ -30 201
Tuhura Biosciences Inc $ 111 - $ 0 -
Anixa Biosciences Inc $ 109 - $ -13 14
Cyteir Therapeutics Inc $ 109 $ 1,545 $ -33 98
Portage Biotech Inc $ 108 - $ -75 11
Adagene Inc $ 107 $ 0 $ -33 77
Lakeshore Biopharma Co Ltd $ 105 $ 81 $ -61 -
Rain Oncology Inc $ 105 - $ -72 48
Elicio Therapeutics Inc $ 104 $ 30 $ -51 32
Societal Cdmo Inc $ 103 $ 95 $ -13 300
Vtv Therapeutics Inc $ 102 $ 5 $ -23 57
Atossa Therapeutics Inc $ 102 - $ -26 10
Bright Minds Biosciences Inc $ 102 - $ -6 57
Corbus Pharmaceuticals Holdings Inc $ 101 $ 2 $ -50 52
Organigram Holdings Inc $ 100 $ 112 $ -11 800
Arca Biopharma Inc $ 100 - $ -54 24
Cassava Sciences Inc $ 96 - $ -73 29
Bgm Group Ltd $ 94 $ 24 $ -2 -
Genelux Corporation $ 93 - $ -31 -
Zentalis Pharmaceuticals Inc $ 93 - $ -224 166
Coya Therapeutics Inc $ 92 - $ -17 42
Nls Pharmaceutics Ltd $ 92 - $ -12 25
Veru Inc $ 91 $ 17 $ 1 89
Immuneering Corporation $ 91 $ 0 $ -62 13
Oramed Pharmaceuticals Inc $ 88 $ 3 $ -28 16
Skye Bioscience Inc $ 86 - $ -33 10
Io Biotech Inc $ 86 - $ -98 19
Whitehawk Therapeutics Inc $ 83 - $ 0 -
Macrogenics Inc $ 82 $ 154 $ -56 341
Pliant Therapeutics Inc $ 78 $ 10 $ -220 26
Aerovate Therapeutics inc $ 78 - $ -59 10
Neonc Technologies Holdings Inc $ 77 - $ 0 -
Essa Pharma inc $ 77 $ 1 $ -28 18
Xbiotech Inc $ 76 $ 8 $ -39 32
Inovio Pharmaceuticals Inc $ 76 $ 8 $ -96 134
Immunic Inc $ 73 - $ -96 21
Igm Biosciences Inc $ 72 - $ -199 224
Pyxis Oncology Inc $ 71 - $ -95 10
Renovorx Inc $ 70 - $ 0 -
Intercure Ltd $ 69 $ 356 $ -64 450
Cumberland Pharmaceuticals Inc $ 66 $ 41 $ -3 91
Biomea Fusion Inc $ 66 - $ -138 80
Pds Biotechnology Corp $ 66 - $ -35 24
Prelude Therapeutics Inc $ 65 - $ -128 17
Zynerba Pharmaceuticals Inc $ 65 - $ -38 12
China Health Industries Holdings Inc $ 65 $ 0 $ -1 -
Clearside Biomedical Inc $ 65 $ 4 $ -31 32
Seres Therapeutics Inc $ 64 $ 13 $ 73 100
Adlai Nortye Ltd $ 64 $ 5 $ -105 50
Immix Biopharma Inc $ 64 - $ -22 21
Viveon Health Acquisition Corp $ 63 - $ 1 11
Medicinova Inc $ 63 - $ -11 13
Vistagen Therapeutics Inc $ 62 $ 0 $ -51 39
Adicet Bio Inc $ 61 $ 39 $ -117 50
Alto Neuroscience Inc $ 61 - $ -63 -
Assertio Holdings inc $ 60 $ 119 $ -31 300
Repare Therapeutics Inc $ 60 $ 69 $ -128 179
Cervomed Inc $ 60 $ 9 $ -19 79
Climb Bio Inc $ 58 - $ -74 -
Connect Biopharma Holdings Limited $ 57 - $ -60 99
Pmv Pharmaceuticals Inc $ 57 - $ -61 47
Sigilon Therapeutics Inc $ 56 $ 18 $ -30 22
Renovaro Inc $ 56 - $ -67 -
Verrica Pharmaceuticals Inc $ 55 $ 7 $ -66 35
Context Therapeutics Inc $ 55 - $ -28 13
Kronos Bio Inc $ 54 $ 9 $ -64 74
Werewolf Therapeutics Inc $ 53 $ 16 $ -72 18
Serina Therapeutics Inc $ 52 $ 0 $ -16 -
Cue Biopharma Inc $ 52 $ 8 $ -41 89
Maia Biotechnology Inc $ 52 - $ -20 13
Xilio Therapeutics inc $ 51 $ 9 $ -54 64
Gain Therapeutics inc $ 51 $ 0 $ -21 18
Applied Therapeutics Inc $ 50 $ 0 $ -44 80
Avalo Therapeutics Inc $ 49 $ 17 $ 73 44
Shattuck Labs Inc $ 49 $ 6 $ -71 202
Pepgen Inc $ 47 - $ -102 22
Fortress Biotech Inc $ 47 $ 58 $ -107 101
Oncolytics Biotech Inc $ 47 - $ -21 37
Mersana Therapeutics inc $ 46 $ 34 $ -74 102
Earth Science Tech Inc $ 45 $ 31 $ 2 -
Annovis Bio Inc $ 45 - $ -29 812
Acrivon Therapeutics Inc $ 45 - $ -84 43
Actinium Pharmaceuticals Inc $ 45 $ 1 $ -38 37
Inflarx N v $ 44 $ 0 $ -48 50
Forte Biosciences Inc $ 43 - $ -35 14
Anebulo Pharmaceuticals Inc $ 42 - $ -8 10
Mural Oncology Plc $ 42 - $ -131 33
Rapid Therapeutic Science Laboratories Inc $ 42 - $ 0 3
Zomedica Corp $ 41 $ 27 $ -102 -
Rafael Holdings Inc $ 40 $ 1 $ -79 18
Tvardi Therapeutics inc $ 39 - $ 0 -
Celularity Inc $ 39 $ 48 $ -35 202
Vyne Therapeutics Inc $ 38 $ 1 $ -42 30
Os Therapies Incoporated $ 38 - $ -13 -
Clene Inc $ 38 $ 0 $ -29 76
Karyopharm Therapeutics Inc $ 37 $ 142 $ -63 325
Transcode Therapeutics Inc $ 37 - $ -26 10
Satsuma Pharmaceuticals Inc $ 36 - $ -65 33
Scynexis Inc $ 36 $ 3 $ -27 99
Lumos Pharma Inc $ 36 $ 2 $ -35 23
Provectus Biopharmaceuticals Inc $ 35 $ 1 $ -5 23
Lava Therapeutics Nv $ 35 - $ 0 -
Jupiter Neurosciences Inc $ 34 - $ 0 -
Lantern Pharma Inc $ 34 - $ -21 22
Lianbio $ 34 - $ -1 129
Reviva Pharmaceuticals Holdings Inc $ 34 - $ -29 12
Hst Global Inc $ 34 - $ 0 -
Barinthus Biotherapeutics Plc $ 34 - $ -65 -
Rein Therapeutics Inc $ 34 - $ 0 -
Iterum Therapeutics Plc $ 34 $ 14 $ -23 18
Eterna Therapeutics Inc $ 33 $ 1 $ -45 31
An2 Therapeutics Inc $ 33 $ 1 $ -45 22
Kezar Life Sciences Inc $ 33 - $ -79 55
Opus Genetics Inc $ 32 - $ 0 -
Onkure Therapeutics Inc $ 32 - $ -60 10
Eagle Pharmaceuticals inc $ 32 $ 258 $ 12 117
Marinus Pharmaceuticals Inc $ 31 $ 32 $ -132 165
Psyence Biomedical ltd $ 31 $ 0 $ -51 65
Rockwell Medical inc $ 30 $ 97 $ 0 56
Allakos Inc $ 30 - $ -71 131
Nrx Pharmaceuticals Inc $ 29 - $ -25 20
Intelgenx Technologies Corp $ 29 $ 1 $ -11 30
Camp4 Therapeutics Corporation $ 28 $ 285 $ -149 333
Aeterna Zentaris Inc $ 28 $ 5 $ -17 35
Abvc Biopharma Inc $ 28 $ 1 $ -6 29
Pulmatrix Inc $ 27 $ 8 $ -10 13
Alx Oncology Holdings Inc $ 26 - $ -130 20
Immunoprecise Antibodies Ltd $ 26 $ 19 $ -21 142
Kala Bio inc $ 26 $ 6 $ -36 38
Generation Bio Co $ 25 $ 25 $ -72 115
Dar Bioscience Inc $ 25 $ 0 $ 0 23
Oragenics Inc $ 24 $ 0 $ -11 12
Medicus Pharma Ltd $ 24 - $ 0 -
Igc Pharma Inc $ 23 $ 1 $ -12 15
Tempest Therapeutics Inc $ 23 - $ -45 18
Mainz Biomed N v $ 23 $ 1 $ -26 120
Boundless Bio Inc $ 23 - $ -66 47
Calcimedica Inc $ 23 - $ -19 -
Nanoviricides inc $ 23 - $ -10 11
Fibrobiologics Inc $ 23 - $ -11 11
Durect Corp $ 21 $ 9 $ -5 61
Lisata Therapeutics Inc $ 21 - $ -19 25
Relmada Therapeutics Inc $ 21 - $ -76 17
Casi Pharmaceuticals inc $ 20 $ 29 $ -39 100
Enlivex Therapeutics Ltd $ 20 - $ -29 29
Ayala Pharmaceuticals Inc $ 20 $ 4 $ -18 11
Lipocine Inc $ 19 $ 14 $ 4 16
Oncotelic Therapeutics Inc $ 19 - $ -5 8
Artelo Biosciences Inc $ 19 - $ -10 11
Q32 Bio Inc $ 19 $ 3 $ -60 42
Mira Pharmaceuticals Inc $ 19 - $ -8 -
Carisma Therapeutics Inc $ 18 $ 20 $ -41 46
Longeveron Inc $ 18 $ 2 $ -26 23
Promis Neurosciences inc $ 17 - $ -1 18
Protagenic Therapeutics Inc new $ 17 - $ -6 10
Lexaria Bioscience Corp $ 17 $ 1 $ -9 27
Alzamend Neuro Inc $ 17 - $ -4 10
Rani Therapeutics Holdings Inc $ 17 - $ -55 105
Aytu Biopharma Inc $ 16 $ 68 $ 2 16
Biovie Inc $ 16 - $ -24 6
Hookipa Pharma inc $ 16 $ 9 $ -73 28
Acer Therapeutics Inc $ 16 - $ -48 40
Marker Therapeutics inc $ 16 $ 6 $ -13 66
23andme Holding Co $ 16 $ 189 $ -281 582
Synlogic Inc $ 16 $ 1 $ 9 35
Leap Therapeutics Inc $ 16 $ 2 $ -69 18
Hoth Therapeutics Inc $ 15 - $ -10 9
Exicure Inc $ 15 $ 7 $ -10 31
Cocrystal Pharma Inc $ 15 $ 2 $ -18 11
Cadrenal Therapeutics Inc $ 15 - $ -11 10
Mei Pharma Inc $ 15 $ 42 $ -32 6
Inhibitor Therapeutics Inc $ 14 - $ -3 5
Universe Pharmaceuticals Inc $ 14 $ 32 $ -6 100
Bioxytran Inc $ 14 - $ -3 -
Rallybio Corporation $ 14 $ 1 $ -48 -
Bullfrog Ai Holdings Inc $ 14 - $ -7 -
Unity Biotechnology Inc $ 14 - $ -28 75
Kiora Pharmaceuticals Inc $ 13 - $ -12 44
Cellectar Biosciences Inc $ 13 - $ -25 12
Minerva Neurosciences Inc $ 13 - $ 6 31
Nextcure Inc $ 13 - $ -50 43
Cell Source Inc $ 13 - $ -5 11
Therapeuticsmd Inc $ 13 $ 1 $ -3 325
Flora Growth Corp $ 13 $ 35 $ -71 76
Talphera Inc $ 12 $ 2 $ -12 -
Prophase Labs Inc $ 12 $ 10 $ -43 24
Imunon Inc $ 12 $ 1 $ -19 25
Neuphoria Therapeutics Inc $ 12 - $ -23 -
Equillium Inc $ 12 $ 41 $ -6 35
Gelesis Holdings Inc $ 12 $ 12 $ -53 64
Geovax Labs Inc $ 11 $ 6 $ -24 16
Acurx Pharmaceuticals inc $ 11 - $ -12 11
Integrated Biopharma Inc $ 11 $ 53 $ 1 50
Shuttle Pharmaceuticals Holdings Inc $ 11 - $ -9 14
Applied Molecular Transport Inc $ 10 - $ -75 10
Accustem Sciences Inc $ 10 - $ -2 -
Edesa Biotech Inc $ 10 - $ -6 36
Allarity Therapeutics Inc $ 10 $ 24 $ -24 14
Agile Therapeutics Inc $ 10 $ 20 $ -16 19
Glycomimetics Inc $ 10 $ 1 $ -50 51
Aprea Therapeutics Inc $ 10 - $ -14 34
Phio Pharmaceuticals Corp $ 10 - $ -7 10
Apexigen Inc $ 10 - $ -40 -
Citius Pharmaceuticals Inc $ 9 - $ -41 51
Eyenovia inc $ 9 $ 0 $ -42 10
Lucy Scientific Discovery Inc $ 9 - $ -4 22
Mustang Bio inc $ 9 - $ -70 32
Orgenesis Inc $ 8 $ 1 $ 35 146
Briacell Therapeutics Corp $ 8 - $ -22 24
Bioxcel Therapeutics Inc $ 8 $ 2 $ -40 116
Ibio inc $ 8 $ 2 $ -22 14
Cyclerion Therapeutics Inc $ 8 $ 2 $ -3 19
Dogwood Therapeutics inc $ 7 - $ -24 13
Evoke Pharma Inc $ 7 $ 12 $ -5 8
Metavia Inc $ 7 - $ 0 -
Alaunos Therapeutics Inc $ 7 - $ -4 12
Kairos Pharma Ltd $ 7 - $ 0 -
Elevai Labs Inc $ 7 - $ 0 -
Aptinyx Inc $ 7 $ 2 $ -66 24
Cingulate Inc $ 6 - $ -16 15
Gt Biopharma Inc $ 6 - $ -13 34
China Pharma Holdings Inc $ 6 $ 4 $ -5 231
Cv Sciences Inc $ 6 $ 14 $ -2 49
Lftd Partners Inc $ 5 $ 36 $ -1 148
Synaptogenix Inc $ 5 - $ 14 10
Nucana Plc $ 5 - $ -28 18
Spyre Therapeutics Inc $ 5 $ 6 $ -209 31
Soligenix inc $ 5 $ 1 $ -10 14
Quoin Pharmaceuticals Ltd $ 5 - $ -10 -
Ainos Inc $ 5 $ 3 $ -15 -
Matinas Biopharma Holdings Inc $ 5 $ 4 $ -6 202
Nabriva Therapeutics Plc $ 5 $ 30 $ -55 40
Aptorum Group Limited $ 4 $ 0 $ -4 12
Galecto Inc $ 4 - $ -18 10
Incannex Healthcare Inc $ 4 - $ -5 16
Xenetic Biosciences Inc $ 4 $ 3 $ -4 11
Immuron Limited $ 4 $ 1 $ -4 12
Guardion Health Sciences Inc $ 4 $ 9 $ 6 -
Rvl Pharmaceuticals Plc $ 4 $ 36 $ -68 -
Genprex Inc $ 4 - $ -19 15
Sunshine Biopharma Inc $ 4 $ 36 $ -5 17
Kineta Inc $ 4 - $ -8 50
Emmaus Life Sciences Inc $ 4 $ 16 $ -4 35
Atreca inc $ 4 - $ -98 75
Lipella Pharmaceuticals Inc $ 3 $ 1 $ -5 16
Biofrontera Inc $ 3 $ 123 $ -8 93
Scienture Holdings Inc $ 3 - $ 9 -
Protokinetix Incorporated $ 3 - $ 0 -
Oncorus Inc $ 3 - $ -91 34
Blue Water Vaccines Inc $ 3 $ 2 $ -57 11
Azitra Inc $ 3 - $ -9 -
Actavia Life Sciences Inc $ 3 $ 0 $ 0 -
Novabay Pharmaceuticals Inc $ 3 $ 9 $ 3 31
Spruce Biosciences Inc $ 3 $ 5 $ -55 22
180 Life Sciences Corp $ 3 - $ -7 10
Aravive Inc $ 3 $ 7 $ -40 31
Aeon Biopharma inc $ 3 - $ 64 10
Galera Therapeutics Inc $ 3 - $ -15 50
Silo Pharma Inc $ 3 $ 0 $ -5 9
Cannapharmarx Inc $ 3 - $ 1 -
Traws Pharma inc $ 3 $ 0 $ -55 -
Entero Therapeutics Inc $ 3 - $ -16 51
Indaptus Therapeutics Inc $ 3 - $ -15 61
Moleculin Biotech Inc $ 2 - $ -23 15
Palatin Technologies Inc $ 2 $ 2 $ -23 11
Novan Inc $ 2 $ 25 $ -32 37
Sonnet Biotherapeutics Holdings Inc $ 2 $ 0 $ -9 13
Aditxt Inc $ 2 $ 0 $ -38 31
Notable Labs Ltd $ 2 - $ -24 -
Bellicum Pharmaceuticals Inc $ 2 $ 1 $ 3 72
Oncternal Therapeutics Inc $ 2 $ 2 $ -35 24
Cns Pharmaceuticals Inc $ 2 $ 0 $ -16 15
60 Degrees Pharmaceuticals Inc $ 2 - $ 0 -
Conduit Pharmaceuticals Inc $ 2 - $ -18 -
One World Products Inc $ 2 $ 0 $ -6 -
Salarius Pharmaceuticals inc $ 2 $ 5 $ -6 8
Lixte Biotechnology Holdings Inc $ 2 - $ -4 16
Jaguar Health Inc $ 2 $ 12 $ -40 69
Galmed Pharmaceuticals Ltd $ 2 $ 2 $ 8 40
Tharimmune Inc $ 2 - $ -12 -
Xortx Therapeutics inc $ 2 $ 1 $ -2 8
Vaccinex Inc $ 2 - $ -19 71
Pasithea Therapeutics Corp $ 2 $ 0 $ -14 24
Dmk Pharmaceuticals Corporation $ 2 $ 4 $ -22 -
Adial Pharmaceuticals Inc $ 2 - $ -9 10
Vbi Vaccines Inc $ 1 $ 9 $ -84 31
Ensysce Biosciences Inc $ 1 $ 5 $ -8 9
Axim Biotechnologies Inc $ 1 $ 0 $ -4 45
Bio path Holdings inc $ 1 - $ -10 9
Cohbar Inc $ 1 - $ -13 -
Aptevo Therapeutics Inc $ 1 $ 13 $ -24 37
Panbela Therapeutics Inc $ 1 - $ -28 26
Avenir Wellness Solutions Inc $ 1 $ 3 $ -3 -
Bespoke Extracts Inc $ 1 $ 1 $ -1 -
Virpax Pharmaceuticals Inc $ 1 - $ -12 5
Timber Pharmaceuticals Inc $ 1 $ 1 $ -15 10
Neubase Therapeutics inc $ 1 - $ -14 7
Dermata Therapeutics Inc $ 1 - $ -12 11
International Stem Cell Corporation $ 1 $ 9 $ 0 8
9 Meters Biopharma Inc $ 1 - $ -46 30
Processa Pharmaceuticals Inc $ 1 - $ -12 12
Impel Pharmaceuticals Inc $ 1 $ 8 $ -74 89
Histogen Inc $ 1 $ 0 $ -12 16
Skinvisible Inc $ 1 $ 0 $ -1 14
Syros Pharmaceuticals Inc $ 1 $ 23 $ -98 47
Trevena inc $ 1 $ 0 $ -34 71
Neptune Wellness Solutions Inc $ 1 $ 39 $ -75 85
Biostax Corp $ 1 - $ -2 -
Painreform Ltd $ 1 - $ -15 -
Evofem Biosciences Inc $ 1 $ 19 $ -9 32
Revelation Biosciences Inc $ 1 - $ -14 8
Infinity Pharmaceuticals Inc $ 1 $ 3 $ -41 41
Zyversa Therapeutics Inc $ 1 - $ -9 -
Gri Bio Inc $ 1 - $ -9 -
Theratechnologies Inc $ 1 $ 82 $ -24 88
Enveric Biosciences Inc $ 1 - $ -10 12
Bioadaptives Inc $ 1 $ 0 $ -1 -
Avenue Therapeutics Inc $ 1 - $ -14 11
Viracta Therapeutics Inc $ 1 - $ -43 12
Contrafect Corporation $ 1 - $ -24 79
Rebus Holdings Inc $ 0 - $ 1 -
Nexien Biopharma Inc $ 0 - $ 0 13
Northwest Biotherapeutics Inc $ 0 $ 1 $ -86 25
Athersys Inc $ 0 $ 5 $ -83 43
Sangui Biotech International Inc $ 0 $ 0 $ 0 10
Lannett Company Inc $ 0 $ 289 $ -274 116
Theriva Biologics inc $ 0 - $ -19 22
Clearmind Medicine Inc $ 0 - $ 0 1
The Greater Cannabis Company Inc $ 0 - $ 0 -
Tff Pharmaceuticals Inc $ 0 $ 1 $ -18 25
Petros Pharmaceuticals inc $ 0 $ 4 $ -23 -
Respirerx Pharmaceuticals Inc $ 0 - $ -3 -
Globestar Therapeutics Corporation $ 0 - $ -1 -
Ocean Biomedical Inc $ 0 - $ -27 22
Reshape Lifesciences Inc $ 0 $ 6 $ -3 65
Regen Biopharma Inc $ 0 $ 0 $ -1 3
Vincerx Pharma Inc $ 0 - $ -23 12
Regenerx Biopharmaceuticals inc $ 0 $ 0 $ -2 6
Baudax Bio Inc $ 0 $ 1 $ -7 16
Bellerophon Therapeutics inc $ 0 - $ -9 45
Humanigen Inc $ 0 $ 2 $ -54 34
Endo International Plc $ 0 $ 2,012 $ -2,450 2,931
Nascent Biotech Inc $ 0 $ 0 $ -2 8
Scorpius Holdings inc $ 0 $ 6 $ -34 -
Biora Therapeutics Inc $ 0 $ 0 $ -32 17
Inmed Pharmaceuticals Inc $ 0 $ 7 $ -3 11
Seelos Therapeutics inc $ 0 $ 2 $ 4 16
Qualigen Therapeutics Inc $ 0 $ 5 $ -9 49
Novaccess Global Inc $ 0 - $ -2 -
Vaxxinity Inc $ 0 - $ -75 54
Scopus Biopharma Inc $ 0 - $ -9 20
Q Biomed inc $ 0 $ 0 $ -1 11
Procyon Corporation $ 0 $ 5 $ 0 -
Adhera Therapeutics Inc $ 0 $ 2,732 $ -3 30
Hepion Pharmaceuticals Inc $ 0 - $ -13 20
Evelo Biosciences Inc $ 0 - $ -82 30
Mallinckrodt Plc $ 0 $ 1,906 $ -163 2,700
American Bio Medica Corporation $ 0 $ 1 $ 1 10
Comera Life Sciences Holdings Inc $ 0 $ 1 $ -12 28
Ampio Pharmaceuticals inc $ 0 $ 0 $ -9 7
Effector Therapeutics Inc $ 0 - $ -35 47
Paxmedica Inc $ 0 - $ -18 10
Molecular Templates Inc $ 0 $ 60 $ -48 62
Clever Leaves Holdings Inc $ 0 $ 17 $ -18 500
Ovid Therapeutics Inc $ 0 $ 1 $ -25 60
Neximmune Inc $ 0 - $ -21 40
Apollomics Inc - - $ 0 20
Alterity Therapeutics Limited - - $ 0 48
Biodexa Pharmaceuticals Plc - $ 0 $ -7 37
Cnbx Pharmaceuticals Inc - $ 1 $ 0 11
Innovation Pharmaceuticals Inc - - $ -3 11
Cyclacel Pharmaceuticals Inc - $ 0 $ -11 62
Altamira Therapeutics Ltd - $ 0 $ -27 32
Grifols Sa - - $ 202 24,000
Quantum Biopharma Ltd - $ 5 $ -14 19
Medicure Inc - $ 17 $ -1 50
Innovation1 Biotech Inc - $ 0 $ -5 -
Neurosense Therapeutics Ltd - - $ 0 11
Propanc Biopharma Inc - - $ -2 10
Proqr Therapeutics N v - - $ 0 48
Avricore Health Inc - $ 2 $ -1 12
Kaya Holdings Inc - $ 1 $ -3 17
Affimed N v - $ 9 $ -119 102
Denali Capital Acquisition Corp - - $ 0 -
Telomir Pharmaceuticals Inc - - $ -17 -
Total Major Pharmaceutical Preparations Industry $ 3,910,693 $ 757,021 $ 73,447 1,235,994
  Recent News from The Largest Companies in Major Pharmaceutical Preparations Industry
Clinical Study

MBX Biosciences Advances Hypoparathyroidism Treatment with Successful Enrollment in Phase 2 Avail Trial of Canvuparat...

'Advancement in Hypoparathyroidism Treatment: MBX Biosciences? Phase 2 Avail Trial of MBX 2109 Concludes Enrollment'MBX Biosciences has reached a significant milestone in the development of its promising treatment for hypoparathyroidism with the completion of participant enrollment in the Phase 2 Avail trial for MBX 2109, also known as Canvuparatide. With...

Announcement

Allarity Therapeutics Advances Share Repurchase Program Amid Promising Developments in Stenoparib Clinical Trials

' for CSIMarket.com 'On March 3, 2025, Allarity Therapeutics, Inc. (NASDAQ: ALLR), a clinical-stage pharmaceutical company focused on developing personalized cancer therapies, announced an authorization from its Board of Directors for a share repurchase program amounting to $5 million. This program is to be executed through February 28, 2026, as part of...

Announcement

Chemomab Therapeutics Faces Challenges Despite Promising Phase 2 Data and Clear Pathway to FDA Approval

'Abstract:'Chemomab Therapeutics Ltd. recently announced its financial results for the fourth quarter and the year ended 2024, revealing mixed outcomes regarding its performance relative to competitors in the pharmaceutical sector. While the company reported promising results from its Phase 2 trial for nebokitug in primary sclerosing cholangitis, its fina...

Announcement

Promising Interim Results from Enlivexs Allocetra Trial Show Significant Pain Reduction in Knee Osteoarthritis Patie...

'Abstract:' Enlivex Therapeutics Ltd. has reported compelling interim results from its Phase I clinical trial of Allocetra, an innovative macrophage reprogramming immunotherapy. This article examines the data from the study, which focuses on the treatment of moderate to severe knee osteoarthritis and highlights the significance of the findings in the con...

Business Update

Zai Lab Limited Positioned for Growth Amid Conference Highlights and Strong Market Performance

Zai Lab Limited, a burgeoning pharmaceutical company with listings on NASDAQ (ZLAB) and the Hong Kong Stock Exchange (9688), is set to enhance its visibility and investor engagement through participation in key investor conferences in March 2025. With events like the Leerink Partners 2025 Global Healthcare Conference and the Jefferies Biotech on the Beach...

Business Update

KalVista Pharmaceuticals Highlights Groundbreaking Sebetralstat Findings for Hereditary Angioedema Treatmen...

KalVista Pharmaceuticals Unveils New Sebetralstat Data at AAAAI WAO 2025 Joint Congress: Promising Advances in Treating Hereditary Angioedema'CAMBRIDGE, Mass. and SALISBURY, England' ?? KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) has announced its commitment to advancing the field of hereditary angioedema (HAE) treatment with the presentation of novel ...

Business Update

Adicet Bio Advances Allogeneic T Cell Therapies with Key Milestones and Upcoming Presentations at SITC 2025

'Adicet Bio Pioneers Allogeneic Gamma Delta T Cell Therapies as It Prepares to Showcase Breakthrough Findings at SITC 2025'In a transformative era for cancer therapy and autoimmune disease treatment, Adicet Bio, Inc. (Nasdaq: ACET), a clinical-stage biotechnology company specializing in allogeneic gamma delta T cell therapies, continues to set the pace in...

Clinical Study

Navigating the Complex Terrain of Bexotegrast Pliant Therapeutics Halts BEACON-IPF Trial Amid Promising Indications

In the constantly shifting landscape of pharmaceutical research, Pliant Therapeutics, Inc., based in South San Francisco, has recently made significant strides, only to find themselves pausing for reassessment. The company announced that it has discontinued its BEACON-IPF Phase 2b trial, which was evaluating the efficacy of bexotegrast in patients sufferi...

Business Update

Emerging Clinical Developments and Strategic Advancements at Acadia Pharmaceuticals

Acadia Pharmaceuticals Inc. has recently shared promising updates regarding its clinical drug candidates and corporate strategies, underscoring the company?s commitment to developing therapies for central nervous system (CNS) disorders and rare diseases. This article interprets three key announcements and assesses their implications for Acadia's market po...

Product Service News

LifeVantage Corporation, a global leader in biohacking and nutrigenomics, continues to forge new pathways t...

'Innovative Expansion: LifeVantage Propels Growth with LV360 Launch, Evolve Compensation Enhancements, and AXIO Lemonade Now Available Permanently'LifeVantage Corporation, a global leader in biohacking and nutrigenomics, continues to forge new pathways to success for its independent consultants and loyal consumers across its Asian markets. The company rec...

Product Service News

ANI Pharmaceuticals Bolsters Patient Care with FDA Approval of New Prefilled Cortrophin Gel Syringe and Reports Subst...

ANI Pharmaceuticals Receives FDA Approval for Purified Cortrophin Gel Prefilled Syringe Amidst Strong Revenue GrowthIn a significant stride within the biopharmaceutical landscape, ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) recently announced the approval of its new presentation of Purified Cortrophin Gel (repository corticotropin injection USP) in a prefil...

Business Update

FDA Approves TEVIMBRA for First-Line Treatment of Advanced Esophageal Squamous Cell Carcinoma

The landscape of oncology treatment continues to evolve as the U.S. Food and Drug Administration (FDA) recently approved TEVIMBRA (tislelizumab-jsgr), a monoclonal antibody, for the first-line treatment of adults with unresectable or metastatic esophageal squamous cell carcinoma (ESCC). This groundbreaking decision marks a significant advancement in the t...

Clinical Study

The Therapeutic Promise of TNX-102 SL A New Dawn for Fibromyalgia Management Unveiled at the 7th International Congress

In a noteworthy presentation at the 7th International Congress on Controversies in Fibromyalgia, Tonix Pharmaceuticals showcased groundbreaking data regarding its innovative therapeutic agent, TNX-102 SL. This sublingual formulation of cyclobenzaprine, designed for effective transmucosal delivery, holds the potential for durable therapeutic activity in th...

Clinical Study

Capricor Therapeutics Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramioce...

Capricor Therapeutics Advances Toward a Milestone in Duchenne Muscular Dystrophy Treatment with FDA Priority ReviewCapricor Therapeutics has taken a significant step forward in the field of genetic medicine, announcing that the U.S. Food and Drug Administration (FDA) has not only accepted but also granted priority review status to their Biologics License...

Clinical Study

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Tr...

Quoin Pharmaceuticals: Advancing Rare Disease Treatment Frontiers with Novel Rapamycin Formulations and Positive Netherton Syndrome Study OutcomesASHBURN, Va.??In a determined stride towards addressing unmet medical needs in the realm of rare and orphan diseases, Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a clinical-stage specialty pharmaceutical company...

Business Update

KalVista Pharmaceuticals, Inc. (NASDAQ KALV), a prominent name in the biopharmaceutical industry, recently ...

'KalVista Pharmaceuticals Announces Strategic Expansion with Key Inducement Grants'KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a prominent name in the biopharmaceutical industry, recently fortified its team by granting inducement options to two newly-hired employees, in alignment with the company's growth trajectory. On March 3, 2025, the compensation ...

Clinical Study

Pioneering Hope in ALS Treatment Tiziana Life Sciences Submits IND Application for Intranasal Foralumab

The landscape of drug development for neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) is fraught with challenges, yet it is also imbued with the potential for groundbreaking advancements. On March 4, 2025, Tiziana Life Sciences, Ltd., a biotechnology company focused on innovative immunomodulation therapies, took a decisive step forw...

Clinical Study

Nuvectis Pharma Advancements in NSCLC Treatment Amidst Financial Challenges

In a significant stride towards improving the treatment landscape for non-small cell lung cancer (NSCLC), Nuvectis Pharma has announced the publication of a research study conducted at the Lerner Research Institute, part of the Cleveland Clinic at Case Western Reserve University. The study highlights the potential of the combination of NXP900 and epiderma...

Product Service News

FibroBiologics Inc. Charts New Frontiers in Mitochondrial Modulation Amidst Financial Fluctuations,

'FibroBiologics Pioneers Mitochondrial Modulation: A New Horizon in Chronic Condition Therapeutics'In the continuously evolving landscape of pharmaceutical science, innovation stands as the keystone to future medical breakthroughs. FibroBiologics Inc., a pioneering force in the industry, has recently taken a monumental step by filing a patent for a ground...

Product Service News

Sensei Biotherapeutics Implements Reverse Stock Split Amidst Competitive Revenue Decline

On June 13, 2025, Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology firm focused on pioneering therapeutics for cancer treatment, announced a significant corporate action: a 1-for-20 reverse stock split of its issued and outstanding shares of common stock. This move, set to take effect at 5:00 p.m. Eastern Time on June 16, 2025, ...

Business Update

Advancements in Immunotherapy and Strategic Partnerships Mercks Key Developments in Oncology

AbstractThe recent approvals of KEYTRUDA (pembrolizumab) signify a substantial advancement in the treatment landscape for head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC). Merck's collaborations further bolster its commitment to innovating therapeutic interventions across multiple oncological pathways. This article out...

Business Update

Pioneering Therapies BeOne Medicines and BeiGene Lead Hematology Innovations,

'Unlocking New Horizons in Hematology: Breakthroughs by BeOne Medicines and BeiGene'San Carlos, California ?? In a major stride within the oncology sector, BeOne Medicines Ltd. (traded on NASDAQ: ONC, HKEX: 06160, SSE: 688235) has unveiled groundbreaking clinical data at the European Hematology Association (EHA) 2025 Congress. This move underscores BeOne'...

Clinical Study

Biomea Fusions BMF-500 Shows Promise in Treating Resistant FLT3-Mutant AML, Reports EHA 2025,

'Abstract:' The 2025 European Hematology Association (EHA) conference highlighted a pivotal advancement in acute leukemia treatment, specifically targeting patients with FLT3-mutant acute myeloid leukemia (AML). Biomea Fusion presented updated preliminary clinical data concerning their novel therapeutic agent, BMF-500, a covalent FLT3 inhibitor. This repo...

Partnership

Harnessing AI-Driven Innovations BullFrog AI and Sygnature Discovery Forge Strategic Collaboration for Revolutionary ...

'Abstract'In an era where the pharmaceutical landscape is rapidly evolving, the integration of artificial intelligence (AI) and machine learning into drug development processes has emerged as a pivotal factor in enhancing efficiency and outcomes. This article discusses the groundbreaking strategic collaboration between BullFrog AI and Sygnature Discovery,...

Clinical Study

Navigating Liquidation Third Harmonic Bios Strategic Exit and Financial Resilience

'Abstract' Third Harmonic Bio Inc. (THB) has recently undergone significant corporate transformations, including stockholder-approved liquidation and dissolution. Meanwhile, financial ratios reveal a dynamic yet challenging fiscal environment. This article explores the implications of these developments for the company and its stakeholders, providing ins...

Business Update

Evolving Chronic Lymphocytic Leukemia Treatment The FDA Approval of BRUKINSAs Tablet Formulation

In a groundbreaking development for oncology therapeutics, BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235) announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of BRUKINSA (zanubrutinib) for all five previously sanctioned indications. Originally introduced to combat chronic lymphocytic leukemia (CLL...

Announcement

Allarity Therapeutics Announces Changes to Board of Directors Amid Strategic Developments in Cancer Treatment

Allarity Therapeutics, Inc. (NASDAQ: ALLR), a pharmaceutical company focused on advancing personalized cancer therapies, has announced a significant change in its Board of Directors. Effective June 30, 2025, Jesper Hiland will be appointed to the board, taking the position previously held by Joseph Vazzano, who will step down after serving for two years.A...

Announcement

Organon Faces Class Action Lawsuit Amidst Underperformance in Q1 2025 Investors to File by July 22 Deadline,

'Organon Shareholder Alert: Investors Urged to Act Amid Class Action Lawsuit Due to Underperformance'In a noteworthy development for shareholders of Organon and Co. (NYSE: OGN), ClaimsFiler has issued a reminder to investors who have suffered losses exceeding $100,000 to file lead plaintiff applications in an ongoing class action lawsuit. The deadline for...

Announcement

PepGen Inc. Legal and Strategic Crossroads Amidst Market Turbulence,

' for CSIMarket.com ''PepGen Inc.: Navigating a Strategic Pivot Amidst Legal and Market Challenges'PepGen Inc. (NASDAQ: PEPG), a biopharmaceutical company, currently finds itself at a crucial juncture. Recently, the law firm Bragar Eagel and Squire, P.C. announced a class action lawsuit against the company, urging investors to contact them for possible c...

Clinical Study

Capricor Therapeutics Advances Duchenne Muscular Dystrophy Program With Positive FDA Inspection Outcome

Capricor Therapeutics, a biotechnology company focused on developing innovative cell and exosome-based therapeutics for rare diseases, has announced significant regulatory progress for its Duchenne Muscular Dystrophy (DMD) program. The company reported the successful completion of a Pre-License Inspection (PLI) of its manufacturing facility located in San...







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com